urban-gro, Inc. Enters into Non-Binding Letter of Intent for Sale of 2WR Subsidiary

Stock Information for Enlivex Therapeutics Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Enlivex Therapeutics Ltd.

urban-gro, Inc. Receives Nasdaq Determination Regarding Continued Listing Requirements
urban-gro, Inc. Receives Nasdaq Delisting Determination; Announces Comprehensive Review of Strategic Alternatives and Provides Corporate Update
urban-gro, Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
urban-gro, Inc. Awarded New Construction Contract with Fogo de Chão
urban-gro, Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
urban-gro, Inc. Awarded Three New Contracts with Fogo de Chão
urban-gro Awarded $1.2M Contract for K-12 Architectural Design with Muscogee County School District
urban-gro Secures $4M Contract as Lead Design Firm for Medical Center

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.